On Assignment, Inc. — Q2 2014 Form 10-Q
Entity note: The supplied filing is for On Assignment, Inc. and subsidiaries, not Everforth Inc. It covers the quarter and six months ended June 30, 2014; financial statements are unaudited. Dollar amounts below are in millions unless stated otherwise.
Business context and reporting period
On Assignment provides contract, contract-to-hire, and direct-hire staffing in technology, healthcare, and life sciences. Its four reportable segments are Apex, Oxford, Physician, and Life Sciences Europe. The company notes that staffing demand is typically stronger in the second and third quarters. Results include the December 2013 acquisitions of CyberCoders and Whitaker; prior-period segment results were retrospectively realigned.
Financial results and liquidity
| Metric | Q2 2014 | Q2 2013 | Six months 2014 | Six months 2013 |
|---|---|---|---|---|
| Revenue | $468.6 | $407.9 | $907.9 | $786.9 |
| Gross profit | $152.7 | $121.3 | $290.3 | $231.4 |
| Gross margin | 32.6% | 29.7% | 32.0% | 29.4% |
| Operating income | $38.6 | $31.8 | $65.9 | $54.6 |
| Net income | $20.8 | $7.3 | $34.7 | $32.0 |
| Diluted EPS | $0.38 | $0.14 | $0.63 | $0.59 |
| Operating cash flow | Not presented quarterly | Not presented quarterly | $25.0 | $30.3 |
Q2 revenue rose 14.9% year over year (8.6% pro forma); first-half revenue rose 15.4% (9.2% pro forma). Management attributed the growth to organic growth of 8.3% in Q2 and 8.8% in the first half, plus acquisitions. Q2 net income benefited from the absence of the prior-year $15.0 million loan-cost write-off. First-half 2013 net income also included a $14.4 million after-tax gain on discontinued operations.
At June 30, cash was $30.8, working capital was $203.1, and total debt was $376.8, versus $399.8 at December 31, 2013. The company had $93.6 available under its revolving facility, a 1.98-to-1.00 funded-debt-to-EBITDA ratio, and reported compliance with debt covenants. Weighted-average debt interest was 2.8%. Cash decreased $6.6 in the first half. Capital expenditures were $9.6 for the period; management estimated full-year 2014 capital expenditures of approximately $19.7.
Material changes and segment performance
- Gross margin expanded 2.9 percentage points in Q2, primarily from a greater share of direct-hire and conversion-fee revenue and improved contract margins. Such fees were 4.9% of Q2 revenue, versus 1.5% a year earlier; CyberCoders contributed $16.0 of Q2 fees.
- Q2 segment revenue growth was Apex 13.5%, Oxford 15.4%, Physician 27.2%, and Life Sciences Europe 11.8%. Growth included acquisition contributions: CyberCoders generated $19.9 of Oxford revenue and Whitaker $7.0 of Physician revenue. Excluding those businesses, Oxford revenue declined about 2.8% and Physician revenue grew 0.8%.
- SG&A increased to $107.9, or 23.0% of revenue, from $84.3, or 20.7%. Management cited CyberCoders’ higher expense profile and $2.1 of acquisition, integration, and strategic-planning costs, mainly severance related to segment realignment.
- First-half operating cash flow declined $5.3 year over year, which management attributed mainly to a $10.4 tax payment related to the Allied Healthcare sale and working-capital movements, including accounts receivable and accrued payroll.
Outlook, risks, and unusual items
- Management believes working capital, revolver availability, and expected operating cash flows will cover debt obligations, working capital, and capital expenditures for the next 12 months. No specific revenue or earnings guidance is provided.
- The board approved a $100 million share-repurchase authorization on July 21, 2014, effective August 4 for two years.
- Potential acquisition-related contingent consideration totaled approximately $16.0 through 2015; the recorded fair value liability was $7.9. Payments depend on acquired businesses meeting performance targets, and valuation relies on significant unobservable assumptions.
- Workers’ compensation and medical malpractice reserves were $32.7, with $20.6 of related receivables. A $10.8 discontinued-operations claim was reported as recoverable from insurance. The company also disclosed $2.9 of unused standby letters of credit and a $1.6 reserve for uncertain tax positions.
- Debt is variable-rate and secured by substantially all assets. The filing estimates that a 100-basis-point rate change would affect annual interest expense by approximately $3.8 before interest-rate-cap effects. Other cited risks include staffing demand and talent availability, competition, acquisition integration, growth management, information systems, litigation, and execution of the strategic plan.
- Management reported effective disclosure controls and no material change in internal control over financial reporting. It did not believe pending ordinary-course legal proceedings would materially affect the company.
Important facts for investors to verify
- Confirm the issuer identity: this document names On Assignment, Inc., despite the request metadata naming Everforth Inc.
- Assess how much reported growth and margin expansion is attributable to CyberCoders and Whitaker versus ongoing performance in existing businesses.
- Monitor receivables and working-capital needs, given the first-half operating cash-flow decline and staffing-related payroll obligations.
- Review debt repayment requirements, covenant headroom, variable-rate exposure, and the potential effect of the share-repurchase program on liquidity and leverage.
- Track acquired-business performance against contingent-payment targets, and developments in insurance recoveries, claims, and uncertain tax positions.